WITHDRAWN: Raising the Bar by Lowering the Target: Integrating PCSK9 Inhibitors Into Hypercholesterolemia Management
Am J Cardiol
.
2018 Aug 16:S0002-9149(18)31653-9.
doi: 10.1016/j.amjcard.2018.08.020.
Online ahead of print.
Authors
Christie M Ballantyne
1
,
Deepak L Bhatt
2
,
Christopher P Cannon
3
,
Sergio Fazio
4
,
Marc S Sabatine
5
Affiliations
1
Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart & Vascular Center, Houston, Texas.
2
Brigham and Women's Hospital, Boston, Massachusetts.
3
Cardiometabolic Trials, Baim Institute for Clinical Research, Boston, Massachusetts.
4
Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.
5
Department of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
PMID:
30301542
DOI:
10.1016/j.amjcard.2018.08.020
No abstract available